Wellington Management Group
RLAY icon

Wellington Management Group’s Relay Therapeutics RLAY Stock Holding History

Wellington Management Group’s Portfolio RLAY Stock Details RLAY Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$2.94M Buy
156,906
+97,398
+164% +$1.41M ﹤0.01% 1546
2026
Q1 		$592K Buy
+59,508
New +$532K ﹤0.01% 1757
2024
Q3 		– Sell
-71,913
Closed -$469K – 2011
2024
Q2 		$469K Buy
71,913
+18,499
+35% +$126K ﹤0.01% 1785
2024
Q1 		$443K Sell
53,414
-47,747
-47% -$466K ﹤0.01% 1822
2023
Q4 		$1.11M Buy
101,161
+12,059
+14% +$102K ﹤0.01% 1608
2023
Q3 		$749K Buy
89,102
+1,369
+2% +$14.7K ﹤0.01% 1646
2023
Q2 		$1.1M Sell
87,733
-762,767
-90% -$9.49M ﹤0.01% 1592
2023
Q1 		$14M Sell
850,500
-200,925
-19% -$3.6M ﹤0.01% 1016
2022
Q4 		$15.7M Buy
1,051,425
+393,040
+60% +$7.52M ﹤0.01% 976
2022
Q3 		$14.7M Sell
658,385
-1,388,967
-68% -$30.5M ﹤0.01% 998
2022
Q2 		$34.3M Buy
2,047,352
+26,838
+1% +$575K 0.01% 787
2022
Q1 		$60.5M Buy
2,020,514
+21,966
+1% +$533K 0.01% 699
2021
Q4 		$61.4M Buy
1,998,548
+590,707
+42% +$18.7M 0.01% 773
2021
Q3 		$44.4M Buy
1,407,841
+139,654
+11% +$4.7M 0.01% 849
2021
Q2 		$46.4M Buy
1,268,187
+423,083
+50% +$13.9M 0.01% 845
2021
Q1 		$29.2M Buy
845,104
+701,573
+489% +$30.4M 0.01% 968
2020
Q4 		$5.97M Sell
143,531
-77,257
-35% -$3.49M ﹤0.01% 1289
2020
Q3 		$9.4M Buy
+220,788
New +$8.42M ﹤0.01% 1120

Other funds holding RLAY

SIAU
SB Investment Advisers (UK) London, United Kingdom $7.66B AUM 20.12% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
CC
Casdin Capital New York $2B AUM 147.21% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
PA
Perceptive Advisors New York $6.66B AUM 360.84% 1-Year Est. Return
CC
Commodore Capital New York $1.68B AUM 375.52% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
NI
Nextech Invest Zurich, Switzerland $2.11B AUM 413.84% 1-Year Est. Return

Wellington Management Group's RLAY Position: Q2 2026 in Review

Wellington Management Group increased its Relay Therapeutics (RLAY) stake by 164% in Q2 2026, buying an estimated $1.41M and bringing the position to 156,906 shares worth $2.94M. The position accounts for ﹤0.01% of the portfolio, ranked #1546.

Wellington Management Group first reported a position in RLAY in Q3 2020 and has held it in 18 quarters since. The position peaked at $61.4M in Q4 2021. 260 funds tracked by Wall St. Rank hold RLAY as of Q2 2026.

  • Wellington Management Group held 156,906 shares of Relay Therapeutics worth $2.94M as of Q2 2026.
  • Wellington Management Group bought 97,398 Relay Therapeutics shares in Q2 2026, an estimated $1.41M.
  • Relay Therapeutics made up ﹤0.01% of Wellington Management Group's portfolio in Q2 2026, its #1546 holding.
  • Wellington Management Group first reported a position in Relay Therapeutics in Q3 2020 and has held it in 18 quarters since.
  • Wellington Management Group's Relay Therapeutics position peaked at $61.4M in Q4 2021.
  • 260 funds tracked by Wall St. Rank held Relay Therapeutics as of Q2 2026.

Based on Wellington Management Group's 13F filing for Q2 2026, filed 14 Aug 2026.